The effect of DZNep on tumor microenvironment through regulating exosomes derived from invasive breast carcinoma

doi:10.19401/j.cnki.1007-3639.2022.09.010

Abstract

Abstract:

Background and purpose: Invasive breast carcinoma is the most prevalent malignancy in women worldwide and has a poor prognosis. Tumor xenobiotics change the tumor microenvironment and participate in the regulation of tumor occurrence, development and metastasis, which provide new ideas for the diagnosis and treatment of tumors. DZNep can target and regulate the degradation of H3K27me3 histone methyltransferase and specifically induce tumor cell apoptosis, thereby inhibiting cell proliferation and migration in a variety of tumors. In this study, we investigated the effect of DZNep on invasive breast carcinoma exosomes and observed its effect on epithelial-mesenchymal transition (EMT) of breast cancer cells by regulating intercellular junctions. Methods: EZH2 expression in invasive breast carcinoma was analyzed using the The Cancer Genome Atlas (TCGA) database and the online analysis software GEPIA2, and the Tumor Immunity Estimation Resources (TIMER) was used to analyze the relationship between EZH2 and the expressions of tumor microenvironment cytokines and EMT-related proteins. Intervention of invasive breast carcinoma MDA-MB-231 with DZNep and extraction of exosomes using differential ultracentrifugation were performed. Exosome membrane-bound protein expression was identified by detecting the expressions of CD9, CD63 and TSG101 using Western blot. The Brownian motion of exosomes was tracked and analyzed by nanoparticle tracking analysis (NTA) technique, and the hydrodynamic diameter and concentration of exosome particles were calculated in combination with the Stokes-Einstein equation. Transmission electron microscopy analysis of the size and shape of exosomes was carried out. The above methods were used to explore the changes of exogenous exosomes in breast cancer induced by DZNep. In addition, Western blot was used to detect the expressions of EZH2, intercellular junction proteins such as occludin, zonula occludens-1 (ZO-1), laminin, aquaporin 4 (AQP4), connexin 43, claudin5 and collagen Ⅵ, and EMT-related proteins such as E-cadherin and vimentin, respectively, to analyze the regulatory mechanism of DZNep on the tumor microenvironment.Results: EZH2 expression was higher in cancer tissues than in normal tissues. High EZH2 expression was positively correlated with the upregulation of both invasive breast carcinoma immune cells and stromal cells in Luminal A, positively correlated with E-cadherin, N-cadherin and vimentin expressions in invasive breast carcinoma, positively correlated with E-cadherin expression and negatively correlated with N-cadherin expression in BRCA-Luminal B, and positively correlated with N-cadherin and vimentin expressions in BRCA-Luminal A (P<0.05). The expressions of CD9, CD63 and TSG101 showed that the exosomes of MDA-MB-231 cells were successfully extracted. After DZNep intervention, the particle size of the exosomes was significantly reduced and the number was decreased. The expressions of intercellular junction proteins including occludin, ZO-1, laminin, AQP4 and connexin 43 were decreased, and the expressions of collagen Ⅵ and claudin 5 (CLDN5) were increased. The expression of EMT-related protein E-cadherin was increased, while the expressions of vimentin was decreased. Conclusion: DZNep reduces the generation of exosomes in BRCA by inhibiting EZH2, which further alters the tumor cell microenvironment and thus affects the EMT phenomenon.

Key words: DZNep, EZH2, Exosomes, Intercellular junction, Epithelial-mesenchymal transition

CLC Number:

R737.9

LÜ Ye, YING Yexia, YANG Wenjing, HOU Yujin, YUAN Chunxiu, CAO Xiangmei. The effect of DZNep on tumor microenvironment through regulating exosomes derived from invasive breast carcinoma[J]. China Oncology, 2022, 32(9): 827-835.

Figures/Tables 4

Fig. 1

Fig. 2

Fig. 3

Fig. 4

References 37

[1]	PECERO M L, SALVADOR-BOFILL J, MOLINA-PINELO S. Long non-coding RNAs as monitoring tools and therapeutic targets in breast cancer[J]. Cell Oncol (Dordr), 2019, 42(1): 1-12.
[2]	YI Y, WU M, ZENG H, et al. Tumor-derived exosomal non-coding RNAs: the emerging mechanisms and potential clinical applications in breast cancer[J]. Front Oncol, 2021, 11: 738945.
[3]	FIGUEROA J, PHILLIPS L M, SHAHAR T, et al. Exosomes from glioma-associated mesenchymal stem cells increase the tumorigenicity of glioma stem-like cells via transfer of miR-1587[J]. Cancer Res, 2017, 77(21): 5808-5819. doi: 10.1158/0008-5472.CAN-16-2524 pmid: 28855213
[4]	马爽, 窦赫, 刘宇琪, 等. 外泌体miRNAs在乳腺癌肿瘤微环境中的研究进展[J]. 现代肿瘤医学, 2021, 29(18): 3295-3299.
	MA S, DOU H, LIU Y Q, et al. Research progress of exosomal miRNAs in the tumor microenvironment of breast cancer[J]. J Mod Oncol, 2021, 29(18): 3295-3299.
[5]	孙蓓丽, 王玉刚. 外泌体与胃癌关系的研究进展[J]. 胃肠病学, 2018, 23(11): 697-700.
	SUN B L, WANG Y G. Advances in study on correlation of exosomes with gastric cancer[J]. Chin J Gastroenterol, 2018, 23(11): 697-700.
[6]	宫伟, 吴霞, 马俊, 等. 外泌体在肿瘤干细胞维持和肿瘤发生与发展中的作用[J]. 实用肿瘤杂志, 2020, 35(1): 79-82.
	GONG W, WU X, MA J, et al. The role of exosomes in cancer stem cell maintenance and tumor development[J]. J Pract Oncol, 2020, 35(1): 79-82.
[7]	HUANG R, JIN X, GAO Y Y, et al. DZNep inhibits Hif-1α and Wnt signalling molecules to attenuate the proliferation and invasion of BGC-823 gastric cancer cells[J]. Oncol Lett, 2019, 18(4): 4308-4316. doi: 10.3892/ol.2019.10769 pmid: 31579098
[8]	吴贝, 李志英, 王俊杰. DZNep在肿瘤治疗中的研究进展[J]. 肿瘤, 2016, 36(8): 938-943.
	WU B, LI Z Y, WANG J J. Research progress in DZNep in tumor therapy[J]. Tumor, 2016, 36(8): 938-943.
[9]	GERGELY J E, DORSEY A E, DIMRI G P, et al. Timosaponin A-Ⅲ inhibits oncogenic phenotype via regulation of PcG protein BMI1 in breast cancer cells[J]. Mol Carcinog, 2018, 57(7): 831-841. doi: 10.1002/mc.22804
[10]	MARGUERON R, REINBERG D. The polycomb complex PRC2 and its mark in life[J]. Nature, 2011, 469(7330): 343-349. doi: 10.1038/nature09784
[11]	RIQUELME E, BEHRENS C, LIN H Y, et al. Modulation of EZH2 expression by MEK-ERK or PI3K-AKT signaling in lung cancer is dictated by different KRAS oncogene mutations[J]. Cancer Res, 2016, 76(3): 675-685. doi: 10.1158/0008-5472.CAN-15-1141 pmid: 26676756
[12]	JUNG H Y, JUN S, LEE M, et al. PAF and EZH2 induce Wnt/β-catenin signaling hyperactivation[J]. Mol Cell, 2013, 52(2): 193-205. doi: 10.1016/j.molcel.2013.08.028
[13]	MOCHIZUKI D, MISAWA Y, KAWASAKI H, et al. Aberrant epigenetic regulation in head and neck cancer due to distinct EZH2 overexpression and DNA hypermethylation[J]. Int J Mol Sci, 2018, 19(12): E3707.
[14]	YAO Y Z, HU H, YANG Y, et al. Downregulation of enhancer of zeste homolog 2 (EZH2) is essential for the Induction of autophagy and apoptosis in colorectal cancer cells[J]. Genes (Basel), 2016, 7(10): E83.
[15]	WEI F Z, CAO Z Y, WANG X, et al. Epigenetic regulation of autophagy by the methyltransferase EZH2 through an MTOR-dependent pathway[J]. Autophagy, 2015, 11(12): 2309-2322. doi: 10.1080/15548627.2015.1117734
[16]	王静如, 巢静波, 陆达伟, 等. 纳米颗粒跟踪分析仪用于二氧化钛纳米颗粒分散及检测[J]. 分析化学, 2021, 49(4): 538-545.
	WANG J R, CHAO J B, LU D W, et al. Dispersion and detection of titanium dioxide nanoparticles based on nanoparticle tracking analysis[J]. Chin J Anal Chem, 2021, 49(4): 538-545.
[17]	WANG F, GAO Y, LV Y, et al. Polycomb-like2 regulates PRC2 components to affect proliferation in glioma cells[J]. J Neurooncol, 2020, 148(2): 259-271. doi: 10.1007/s11060-020-03538-0
[18]	吴大平, 吴焕良, 郑文宏, 等. IL-6调控miR-204及Notch1促进乳腺癌细胞增殖、迁移和侵袭[J]. 现代免疫学, 2021, 41(5): 380-385.
	WU D P, WU H L, ZHENG W H, et al. IL-6 promotes proliferation, migration and invasion of breast cancer cells by regulating miR-204 and Notch1[J]. Curr Immunol, 2021, 41(5): 380-385.
[19]	KOSAKA N, IGUCHI H, HAGIWARA K, et al. Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis[J]. J Biol Chem, 2013, 288(15): 10849-10859. doi: 10.1074/jbc.M112.446831 pmid: 23439645
[20]	苏建伟, 韦庆臣, 周喜汉. 肿瘤来源的外泌体在肿瘤微环境调控作用的研究进展[J]. 右江医学, 2016, 44(4): 456-458.
	SU J W, WEI Q C, ZHOU X H. Progress in the regulation of tumor-derived exosomes in tumor microenvironment[J]. Chin Youjiang Med J, 2016, 44(4): 456-458.
[21]	CREA F, FORNARO L, BOCCI G, et al. EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis[J]. Cancer Metastasis Rev, 2012, 31(3/4): 753-761. doi: 10.1007/s10555-012-9387-3
[22]	FERRARO A, BONI T, PINTZAS A. EZH2 regulates cofilin activity and colon cancer cell migration by targeting ITGA2 gene[J]. PLoS One, 2014, 9(12): e115276.
[23]	CHENG L L, ITAHANA Y, LEI Z D, et al. TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep)[J]. Clin Cancer Res, 2012, 18(15): 4201-4212. doi: 10.1158/1078-0432.CCR-12-0036 pmid: 22675170
[24]	BRACKEN A P, PASINI D, CAPRA M, et al. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer[J]. EMBO J, 2003, 22(20): 5323-5335. pmid: 14532106
[25]	CHU C S, LO P W, YEH Y H, et al. O-GlcNAcylation regulates EZH2 protein stability and function[J]. Proc Natl Acad Sci USA, 2014, 111(4): 1355-1360. doi: 10.1073/pnas.1323226111
[26]	MAHARA S, LEE P L, FENG M, et al. HIFI-α activation underlies a functional switch in the paradoxical role of Ezh2/PRC2 in breast cancer[J]. Proc Natl Acad Sci U S A, 2016, 113(26): E3735-E3744.
[27]	TAKAHASHI K, OTA Y, KOGURE T, et al. Circulating extracellular vesicle-encapsulated HULC is a potential biomarker for human pancreatic cancer[J]. Cancer Sci, 2020, 111(1): 98-111. doi: 10.1111/cas.14232
[28]	NIETO M A, HUANG R Y J, JACKSON R A, et al. Emt: 2016[J]. Cell, 2016, 166(1): 21-45. doi: 10.1016/j.cell.2016.06.028 pmid: 27368099
[29]	戴京, 叶茂. 去泛素化酶在肿瘤上皮间质转化中的作用[J/OL]. 中国生物化学与分子生物学报: 1-12.
	DAI J, YE M. The role of deubiquitinase in epithelial-mesenchymal transition of tumors[J/OL]. Chin J Biochem Mol Biol: 1-12.
[30]	LAMOUILLE S, XU J, DERYNCK R. Molecular mechanisms of epithelial-mesenchymal transition[J]. Nat Rev Mol Cell Biol, 2014, 15(3): 178-196. doi: 10.1038/nrm3758
[31]	史博, 朱俊玲, 张晋, 等. EZH2调节E-cadherin对胶质瘤细胞生物学行为影响的实验研究[J]. 临床肿瘤学杂志, 2021, 26(2): 117-121.
	SHI B, ZHU J L, ZHANG J, et al. Effect of EZH2 on proliferation, invasion and migration of glioma cells through regulating E-cadherin[J]. Chin Clin Oncol, 2021, 26(2): 117-121.
[32]	D’ANGELO V, IANNOTTA A, RAMAGLIA M, et al. EZH2 is increased in paediatric T-cell acute lymphoblastic leukemia and is a suitable molecular target in combination treatment approaches[J]. J Exp Clin Cancer Res, 2015, 34: 83. doi: 10.1186/s13046-015-0191-0
[33]	ZHOU X, ZANG X, GUAN Y, et al. Targeting enhancer of zeste homolog 2 protects against acute kidney injury[J]. Cell Death Dis, 2018, 9(11): 1067. doi: 10.1038/s41419-018-1012-0 pmid: 30341286
[34]	THIERY J P, ACLOQUE H, HUANG R Y J, et al. Epithelial-mesenchymal transitions in development and disease[J]. Cell, 2009, 139(5): 871-890. doi: 10.1016/j.cell.2009.11.007 pmid: 19945376
[35]	刘俊骥, 刘兰, 颜赞芳, 等. 细胞粘附蛋白、HER-2、ZO-1和VEGF与弥漫型胃癌侵袭转移的相关性研究[J]. 实用癌症杂志, 2019, 34(5): 714-717.
	LIU J J, LIU L, YAN Z F, et al. Study on the relationship between HER-2ZO-1 and VEGF and invasion and metastasis of diffuse gastric carcinoma[J]. Pract J Cancer, 2019, 34(5): 714-717.
[36]	李英彬, 孙圣荣. 水通道蛋白4在乳腺癌细胞侵袭转移中的作用[J]. 临床外科杂志, 2020, 28(1): 54-57.
	LI Y B, SUN S R. Effect of aquaporin AQP4 in invasion and metastasis of breast cancer cells[J]. J Clin Surg, 2020, 28(1): 54-57.
[37]	CHEN Q, BOIRE A, JIN X, et al. Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer[J]. Nature, 2016, 533(7604): 493-498. doi: 10.1038/nature18268